Skip to main content
SpringerLink
Log in

Behandlung der Syphilis

Deutsche und internationale Leitlinien—ein Vergleich

Syphilis treatment

German and international guidelines—a comparison

  • Leitthema: 100 Jahre Treponema pallidum
  • Published:
Der Hautarzt Aims and scope Submit manuscript

Zusammenfassung

Leitlinien sind ein wichtiges Instrument zur Verbesserung und Sicherung der Qualität der medizinischen Versorgung. Sie sollen einen ständig aktualisierten Konsens auf dem Boden der aktuellsten wissenschaftlichen Daten darstellen. Die erstmals 2001 veröffentlichten Leitlinien der Deutschen STD Gesellschaft (DSTDG) zur Diagnostik und Therapie der Syphilis bedurften dringend einer Überarbeitung. In der vorliegenden Übersicht werden die von der DSTDG aktualisierten Leitlinien zur Syphilistherapie (Stand Oktober 2004) den sonstigen in Europa angewandten Leitlinien zur Therapie der Syphilis gegenübergestellt.

Abstract

Guidelines are an important instrument for improving the quality of medical care. In 2001, the German STD Society (DSTDG) published guidelines for syphilis diagnostics and treatment. For two reasons, these guidelines had to be reviewed urgently: Firstly, there is an obvious “renaissance” of syphilis among men having sex with men, which is complicated by a frequent comorbidity with HIV infection. Secondly, the standard drug for syphilis treatment in Germany, clemizole penicillin, has no longer been available since July 2003. In this article, the new German guidelines for syphilis treatment 2004, published by the DSTDG, are compared with other syphilis guidelines, which are valid for the European countries, i.e., the CDC, UK, Russian, and European guidelines 2002.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Akovbian V, Filatova E (2002) Management of syphilis infected patients in Russia. http://www.sti-taskforce.org/documents.html

  2. Augenbraun MH, Rolfs R (1999) Treatment of syphilis, 1998: nonpregnant adults. Clin Inf Dis 28 [Suppl 1]: 21–28

    Google Scholar 

  3. Berry CD, Hooton TM, Collier A, Lukehart S (1987) Neurologic relapse after benzathine penicillin therapy for secondary syphilis in a patient with HIV infection. N Engl J Med 316: 1587–1589

    Google Scholar 

  4. Brockmeyer NH (2001) Syphilis. In: Petzoldt D, Gross G (Hrsg) Diagnostik und Therapie sexuell übertragbarer Krankheiten. Leitlinien 2001 der Deutschen STD-Gesellschaft. Springer, Berlin Heidelberg New York Tokio, S 101–111

  5. Centers for Disease Control and Prevention (2002) Sexually transmitted disease treatment guidelines 2002. MMWR Morb Mortal Wkly Rep 51: 18–28, http://www.cdc.gov/std/treatment

  6. Centers for Disease Control and Prevention (2004) Azithromycin treatment failures in syphilis infections—San Francisco, California, 2002–2003. MMWR Morb Mortal Wkly Rep 53: 197–198

    Google Scholar 

  7. Cumberland MC, Turner TB (1949) The rate of multiplication of Treponema pallidum in normal and immune rabbits. Am J Syph Gonor Ven Dis 33: 201–212

    Google Scholar 

  8. Duncan WC (1989) Failure of erythromycin to cure secondary syphilis in a patient infected with the human immunodeficiency virus. Arch Dermatol 125: 82–84

    Google Scholar 

  9. Eagle H, Fleischman R, Musselman AD (1950) The effective concentration of penicillin in vitro and in vivo for streptococci, pneumococci and Treponema pallidum. J Bacteriol 59: 625–643

    Google Scholar 

  10. French P (2002) Syphilis Guidelines Revision Group. UK national guidelines on the management of late syphilis 2002. http://www.mssvd.org.uk

  11. Giles AJ, Lawrence AG (1979) Treatment failure with penicillin in early syphilis. Br J Vener Dis 55: 62–64

    Google Scholar 

  12. Goh B, Voorst Vader PC van (2001) European guideline for the management of syphilis. Int J STD AIDS 12 [Suppl 3]: 14–26, http://www.iusti.org

  13. Goh B (2002) Syphilis Guidelines Revision Group. UK national guidelines on the management of early syphilis 2002. http://www.mssvd.org.uk

  14. Gruber F, Kastelan M, Cabrijan L, Simonic E, Brajac I (2000) Treatment of early syphilis with azithromycin. J Chemother 12: 240–243

    Google Scholar 

  15. Hook EW 3rd, Martin DH, Stephens J, Smith BS, Smith K (2002) A randomized, comparative pilot study of azithromycin versus benzathine penicillin G for treatment of early syphilis. Sex Transm Dis 29: 486–490

    Google Scholar 

  16. Idsoe O, Guthe T, Willcox RR (1972) Penicillin in the treatment of syphilis: the experience of three decades. Bull World Health Organ 47 [Suppl 1]: 1–68

    Google Scholar 

  17. Johns DR, Tierney M, Felefestein D (1987) Alterations in the natural history of neurosyphilis by concurrent infection with the human immunodeficiency virus. N Engl J Med 316: 1569–1572

    Google Scholar 

  18. Korting HC, Walther D, Riethmüller U et al. (1986) Comparative in vivo susceptibility of Treponema pallidum to ceftizoxime, ceftriaxone and penicillin G. Chemotherapy 32: 352–355

    Google Scholar 

  19. Lukehart SA, Hook EW, Baker-Zander SA et al. (1988) Invasion of the central nervous system by Treponema pallidum: implications for diagnosis und treatment. Ann Intern Med 109: 855–862

    Google Scholar 

  20. Lukehart SA, Godornes C, Molini BJ et al. (2004) Macrolide resistance in Treponema pallidum in the United States and Ireland. N Engl J Med 351: 154–158

    Google Scholar 

  21. Malone JL, Wallace MM, Hendrick BB et al. (1995) Syphilis and neurosyphilis in a HIV type 1 seropositive population: evidence for frequent serological relapse after therapy. Am J Med 99: 55–63

    Google Scholar 

  22. Marra CM, Boutin P, McArthur JC et al. (2000) A pilot study evaluating ceftriaxone and penicillin G as treatment agents for neurosyphilis in human immunodeficiency virus-infected individuals. Clin Infect Dis 30: 540–544

    Google Scholar 

  23. Mashkilleyson AL, Gomberg MA, Mashkilleyson N, Kutin SA (1996) Treatment of syphilis with azithromycin. Int J STD AIDS 7 [Suppl 1]: 13–15

    Google Scholar 

  24. Nau R, Prange HW, Muth P et al. (1993) Passage of cefotaxime and ceftriaxone into the cerebrospinal fluid of patients with uninflamed meninges. Antimicrob Agents Chemother 27: 1518–1524

    Google Scholar 

  25. Parkes R, Renton A, Meheus A, Laukamm-Josten U (2004) Review of current evidence and comparison of guidelines for effective syphilis treatment in Europe. Int J STD AIDS 15: 73–88

    Google Scholar 

  26. Pehamberger H (1981) Single dose treatment of primary syphilis with Benzathine penicillin. Wien Med Wochenschr 131: 213–215

    Google Scholar 

  27. Rompalo A (2004) Syphilis and HIV infection. Update 2004. http://www.uptodate.com

  28. Rolfs RT (1995) Treatment of syphilis, 1993. Clin Infect Dis 20 [Suppl 1]: 23–38

    Google Scholar 

  29. Rolfs RT, Joesoef RM, Hendershot EF (1997) A randomised trial of enhanced therapy for early syphilis in patients with and without HIV infection. N Engl J Med 337: 307–314

    Google Scholar 

  30. Schöfer H, Vogt HJ, Milbradt R (1989) Ceftriaxone for the treatment of primary and secondary syphilis. Chemotherapy 35: 140–145

    Google Scholar 

  31. Schöfer H, Imhof M, Thoma-Greber E et al. (1996) Active syphilis in HIV infection: a multicentre retrospective survey. The German AIDS Study Group (GASG). Genitourin Med 72: 176–181

    PubMed  Google Scholar 

  32. Smith C, Kamp M, Olansky S, Price E (1956) Benzathine penicillin G in the treatment of syphilis. Bull World Health Organ 15: 1087–1096

    Google Scholar 

  33. Smith NH, Musher DM, Huang DB, Rodriguez PS, Dowell ME, Ace W, White AC Jr (2004) Response of HIV-infected patients with asymptomatic syphilis to intensive intramuscular therapy with ceftriaxone or procaine penicillin. Int J STD AIDS 15: 328–332

    Google Scholar 

  34. Stapleton JT, Stamm LV, Bassford PJ (1985) Potential for development of antibiotic resistance in pathogenic treponemes. Rev Infect Dis 7 [Suppl 2]: 314–317

    Google Scholar 

  35. Verdon MS, Handsfield HH, Johnson RB (1994) Pilot study of azithromycin for treatment of primary and secondary syphilis. Clin Infect Dis 19: 486–488

    Google Scholar 

  36. Voorst Vader PC van (1998) Syphilis management and treatment. Dermatol Clinics 16: 699–711

    Google Scholar 

  37. World Health Organization (1982) Treponemal infections. Report of a WHO Scientific Group. WHO Technical Report Series No 674, Geneva

Download references

Interessenkonflikt:

Der korrespondierende Autor versichert, dass keine Verbindungen mit einer Firma, deren Produkt in dem Artikel genannt ist, oder einer Firma, die ein Konkurrenzprodukt vertreibt, bestehen.

Author information

Authors and Affiliations

  1. Zentrum der Dermatologie und Venerologie, Johann Wolfgang Goethe-Universität Frankfurt/Main

    H. Schöfer

  2. Zentrum der Dermatologie und Venerologie, Johann Wolfgang Goethe-Universität, Theodor-Stern-Kai 7, 60590, Frankfurt

    H. Schöfer

Authors
  1. H. Schöfer
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to H. Schöfer.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Schöfer, H. Behandlung der Syphilis. Hautarzt 56, 141–150 (2005). https://doi.org/10.1007/s00105-004-0870-9

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00105-004-0870-9

Schlüsselwörter

Keywords

Search

Navigation